ribavirin has been researched along with Hyperamylasemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, WC; Cui, N; Fan, YD; Guo, CT; Hu, JG; Liu, W; Lu, QB; Qin, SL; Wang, HY; Wang, LY; Yang, ZD; Zhang, SY; Zhang, XA | 1 |
1 other study(ies) available for ribavirin and Hyperamylasemia
| Article | Year |
|---|---|
Common adverse events associated with ribavirin therapy for Severe Fever with Thrombocytopenia Syndrome.
Topics: Anemia; Antiviral Agents; Female; Hemoglobins; Humans; Hyperamylasemia; Male; Middle Aged; Phlebotomus Fever; Phlebovirus; Prospective Studies; Ribavirin; Time Factors; Treatment Outcome | 2015 |